NPF News

The National Pancreas Foundation Announces the Designation of Seven Additional NPF Centers for the Care and Treatment of Pancreatitis BETHESDA, MD – February 19, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of seven additional National Pancreas Foundation Centers. …

Read More

Here is a letter from a patient to her disease. Much of this will strike a chord with patients of pancreas disease. This young woman has familial chylomicronemia syndrome (FCS), which is a rare genetic disorder that causes the body to become unable to effectively clear lipid particles called chylomicrons. As a result, patients have …

Read More

Boston Neighborhood Network (BNN) recently interviewed NPF co-founder Jane Holt to discuss the newly designated NPF Centers as well as progress being made in the treatment of pancreatic diseases.

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy. According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer diagnosed in the U.S. in 2015, …

Read More

National Pancreas Foundation to Honor Dr. Marty Makary with 2015 Nobility in Science Award  BETHESDA, MD – Oct. 14, 2015 – The National Pancreas Foundation will honor Dr. Marty Makary of Johns Hopkins Medicine with the 2015 Nobility in Science award, which recognizes individuals who have made outstanding achievements in the areas of pancreatic research …

Read More